Oculis Holding AG (OCS) Non-Current Deferred Tax Liability (2021)

Oculis Holding AG (OCS) recorded quarterly Non-Current Deferred Tax Liability of $11929.5 in Q4 2021.

Oculis Holding AG (OCS) Non-Current Deferred Tax Liability (2021) Analysis & Trends

Oculis Holding AG's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $11929.5 for Q4 2021.

In Q4 2021, Non-Current Deferred Tax Liability changed N/A year-over-year to $11929.5; the TTM figure through Dec 2021 stood at $11929.5 (changed N/A YoY), while the FY2021 annual figure was $11929.5, changed N/A from the prior year.
Non-Current Deferred Tax Liability was $11929.5 for Q4 2021 at Oculis Holding AG.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11929.5 in Q4 2021 to a low of $11929.5 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn
9	Abivax	90.15 Bn	90.15 Bn	-
10	Oculis Holding AG	8.23 Bn	7.92 Bn	-

Download Data

Date	Value
Dec 31, 2021	11,929.52
Dec 31, 2021	11,929.52